pharmaceutical market research provides up-to-date listings of new and current pharma market research with sample pages and Tables of Contents to help make the right choices when buying off-the-shelf market research reports.

Free Research Report Download:
The Cancer Market Outlook To 2014: Competitive landscape, market size, pipeline analysis and growth opportunities
The Cancer Market Outlook To 2014


Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy
Business Market Research
Energy Market Research
Financial Market Research
Pharmaceutical Market Research
Telecoms Market Research

Home > Market Research > Biotechnology > DNA Sequencing: Emerging Technologies and Applications

DNA Sequencing: Emerging Technologies and Applications

DNA Sequencing: Emerging Technologies and Applications

Table of Contents

Market Study
Published: July 2010
Pages: 297
Tables: 68
From: GBP 3344.00   Buy Now!
Research from: Business Communications Company Inc.
Sector: Biotechnology


This Report:

  • The worldwide market for sequencing products will grow from an estimated $1.3 billion in 2010 to more than $3.3 billion by 2015, a compound annual growth rate (CAGR) of 20.5% over the next 5 years.
  • Life-science research and drug discovery and development applications represent the two largest markets for DNA sequencing revenues, accounting for an estimated $920.1 million in 2010. These markets are forecast to grow at a compound annual growth rate (CAGR) of 13% to reach nearly $1.7 billion in 2015.
  • Emerging applications, including personal genomics and clinical diagnostics, are forecast to account for $541.4 million by the year 2015, an increase from $15.5 million in 2010 representing a 103.5% compound annual growth rate (CAGR).

INTRODUCTION

STUDY GOALS AND OBJECTIVES

BCC’s goal for this study is to determine the status of current and newer generation DNA (deoxyribonucleic acid) sequencing technologies, products and services and to assess their worldwide growth potential over a 5-year period from 2010 to 2015. Our particular interest is to characterize and quantify the DNA sequencing products market by application, technology, analysis type, geography, and end user. Sequencing applications market segments that will provide substantial future growth opportunities for next-generation DNA sequencing companies include research, drug discovery and development, bacterial genomics, agricultural genomics, clinical diagnostics, and personal genomics. Applications providing growth opportunities for genomics suppliers include sequence capture and bioinformatics.

Our main objective is to present a comprehensive discussion of DNA sequencing technologies; industry structure; key applications; major sequencing initiatives; global markets; intellectual property (IP) and patenting status; and sequencing companies. This discussion will assist life-science companies in strategic planning to meet the challenges and opportunities of this dynamic industry.

REASONS FOR DOING THE STUDY

The Human Genome Project (HGP) moved DNA sequencing technology to the forefront of life-science research as a genetic analysis tool. The HGP relied heavily on Sanger sequencing by capillary electrophoresis to decipher the DNA sequence of the bases in the human genome. A significant outcome of the HGP was improvements in the efficiency and costs of DNA sequencing. During this time period, the DNA sequencing industry consolidated, resulting in one dominant company, Applied Biosystems.

Beginning in 2005, new DNA sequencing technologies have emerged that are radically changing the structure of the industry and opening up exciting new market applications. Contributing to the rise of these new sequencing technologies are advances in nanotechnology, microfluidics, imaging, enzymology, and bioinformatics. Based on these market and technology dynamics, it is timely to examine the future DNA sequencing markets.

Ongoing discoveries in nanotechnology, bioinformatics, microfluidics, imaging, enzymology, and bioinformatics are revolutionizing many life-science fields, and providing novel platforms for next-generation DNA sequencing. At the same time this is occurring, there is a growing market demand for analysis of the genomes of many species and cancers and for understanding the role of genetic variation among individuals in disease. The genetic analysis industry seeks to meet these needs with tools such as microarrays, real-time polymerase chain reaction (RT-PCR), and DNA sequencing instruments.

Next-generation sequencing has created new opportunities to compete with traditional genetic analysis tools, and this report examines this trend and its significance for companies supplying DNA sequencing products and services.

Next-generation, and follow-on, third-generation DNA sequencing technologies will continue to change the dynamics of the DNA sequencing industry and create novel market opportunities. This report analyzes these trends and their impact on the future markets for DNA sequencing technologies.

Given the evolving nature of this industry, it is particularly timely to gain an understanding of these technological and competitive forces and the impact on the genetic analysis markets.

INTENDED AUDIENCE

We have compiled a study of next- and third-generation technologies that will be commercially important in the major end-user segments of life-science research, drug discovery and development, forensics and human identification, bacterial genomics, agricultural genomics, clinical diagnostics, and personal genomics. We present both Sanger sequencing and follow-on-generation technologies as well as market growth driving forces, major sequencing initiatives, product formats, market applications, industry alliances, future market potential, and product sales forecasts for the period 2010 through 2015. We forecast the use of sequencing products for these end-user segments: major sequencing centers, academic genome centers, government labs, pharmaceutical/biotech labs, small to mid-size labs, and sequencing service labs.

This study will be of particular interest to life-science research tools suppliers, pharmaceutical, diagnostics, nanotechnology, bioinformatics, semiconductor, and biotechnology companies. It will also be valuable to companies involved in genome sequencing projects, sequencing centers, manufacturers of microarrays, suppliers of molecular diagnostics assays, bioinformatics companies, and cancer researchers and clinicians.

SCOPE OF REPORT

The study scope includes DNA sequencing technologies likely to be commercialized within the next 5 years. Sanger, next-generation, and third-generation technologies are included. Each technology is analyzed to determine its market status, impact on future market segments, and forecast growth from 2010 through 2015. Advantages and limitations of each technology together with market driving forces are discussed.

BCC examines the sequencing industry structure, strategic industry alliances and acquisitions, and sequencing patents. The strategies of the main sequencing companies are discussed. The markets for sequencing applications, including de novo whole-genome sequencing, resequencing, ChipSeq, MethylSeq, and RNASeq, are analyzed.

METHODOLOGY

BCC surveyed key users and producers in each of the market applications that will be commercially important during the next 5 years: research, drug discovery and development, forensics and human identification (ID), bacterial genomics, agricultural genomics, clinical diagnostics, and personal genomics. Based on our industry discussions and market analysis, we project the future applications of sequencing platforms and forecast sales revenues for 2010 through 2015.

The sequencing market is analyzed by technology, product type, application, customer, analysis type, geography, and genome type, with forecasts of market demand from 2010 through 2015. We analyze which applications and analyses will be important to the future of DNA sequencing, and the customer groups that will be consumers of the technologies. We also analyze the impact of other genetic analysis technologies like microarrays on the growth of sequencing.

Top of Page

Table of Contents

CHAPTER ONE: INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
INTENDED AUDIENCE
SCOPE OF REPORT
METHODOLOGY
INFORMATION SOURCES
RELATED BCC REPORTS
ANALYST CREDENTIALS
BCC ONLINE SERVICES
DISCLAIMER
CHAPTER TWO: EXECUTIVE SUMMARY
SUMMARY TABLE GLOBAL VALUE OF DNA SEQUENCING PRODUCTS, BY END-USE APPLICATION, THROUGH 2015 ($ MILLIONS)
SUMMARY FIGURE GLOBAL VALUE OF DNA SEQUENCING PRODUCTS, BY END-USE APPLICATION, 2009-2015 ($ MILLIONS)
CHAPTER THREE: OVERVIEW
INTRODUCTION
TABLE 1 SCOPE OF THIS REPORT
MARKET POTENTIAL OF DNA SEQUENCING PRODUCTS
TABLE 2 GLOBAL VALUE OF DNA SEQUENCING WORKFLOW PRODUCTS, BY TYPE, THROUGH 2015 ($ MILLIONS)
SEQUENCING INDUSTRY GROWTH DRIVING FORCES
TABLE 3 DNA SEQUENCING KEY GROWTH DRIVING FORCES
SEQUENCING PRODUCTS
SEQUENCING INSTRUMENTS
SEQUENCING CONSUMABLES
SEQUENCING PRODUCT LIFE CYCLE STATUS
TABLE 4 PRODUCT LIFE CYCLE STATUS OF SEQUENCING PLATFORMS
COMMERCIAL STATUS
SEQUENCING INDUSTRY
TABLE 5 SEQUENCING INSTRUMENT COMPETITORS, BY TECHNOLOGY
CHAPTER FOUR: DNA SEQUENCING TECHNOLOGIES
GENETIC ANALYSIS
FIGURE 1 CENTRAL MOLECULAR BIOLOGY DOGMA
FIGURE 2 DNA, MRNA, AND GENETIC VARIATION
TABLE 6 SCOPE OF KEY GENETIC ANALYSIS TECHNOLOGIES
HISTORY OF DNA SEQUENCING
TABLE 7 DNA SEQUENCING HISTORICAL TIMELINE
FIGURE 3 SEQUENCING COST TREND, BASE PAIRS SEQUENCED PER DOLLAR
FIGURE 4 SEQUENCING THROUGHPUT TREND
FIGURE 5 HUMAN GENOME SEQUENCING COST TREND, 2000-2015 (DOLLARS)
FIGURE 6 $1,000 GENOME PRODUCT SPACE
OVERVIEW OF SEQUENCING TECHNOLOGIES
TABLE 8 DNA SEQUENCING TECHNOLOGY PLATFORM COMPARISON
SANGER SEQUENCING
SANGER SEQUENCING TECHNOLOGY
FIGURE 7 DDNTP CHEMICAL STRUCTURE
FIGURE 8 SANGER SEQUENCING WORKFLOW
SANGER SEQUENCING COSTS
FIGURE 9 COST BREAKDOWN FOR SEQUENCING A SINGLE HUMAN GENOME, USING 2005 SANGER SEQUENCER TECHNOLOGY (%)
LIMITATIONS OF SANGER SEQUENCING
TABLE 9 LIMITATIONS OF SANGER SEQUENCING TECHNOLOGY
TECHNOLOGY DEVELOPMENTS IN SANGER SEQUENCING
TABLE 10 IMPROVEMENTS IN SANGER SEQUENCING TECHNOLOGY
NEXT-GENERATION SEQUENCING TECHNOLOGIES
INTRODUCTION
NEXT-GENERATION SEQUENCING WORKFLOW
TABLE 11 NEXT-GENERATION SEQUENCING WORKFLOW STEPS
FIGURE 10 NEXT-GENERATION SEQUENCING TECHNOLOGIES
TABLE 12 WORKFLOW COMPARISON OF SELECTED NEXTGENERATION DNA SEQUENCING PLATFORMS
TABLE 13 NEXT-GENERATION SEQUENCE PLATFORMS
FIGURE 11 SCHEMATIC COMPARISON OF ROCHE/454, LIFE TECHNOLOGIES, AND ILLUMINA SEQUENCING PLATFORMS
TABLE 14 NEXT-GENERATION SEQUENCING PLATFORM ADVANTAGES AND LIMITATIONS
SEQUENCING BY SYNTHESIS WITH REVERSIBLE TERMINATORS
FIGURE 12 SEQUENCING BY SYNTHESIS: REVERSIBLE TERMINATOR REACTION
PYROSEQUENCING
FIGURE 13 SEQUENCING BY SYNTHESIS: PYROSEQUENCING REACTION
SEQUENCING BY LIGATION
Sample Preparation
Sequencing Reaction
FIGURE 14 SCHEMATIC OF SOLID SEQUENCING BY LIGATION
Cycle 1
Cycle 2
Cycles 3 to 5
Decoding
FIGURE 15 DECODING SOLID COLOR DATA
THIRD-GENERATION SEQUENCING
Single-molecule Sequencing by Synthesis
Nanopore Sequencing
FIGURE 16 SINGLE-MOLECULE SEQUENCING BY SYNTHESIS
FIGURE 17 NANOPORE SEQUENCING WORKFLOW AND TECHNOLOGY APPROACHES
SEQUENCING TECHNOLOGY PLATFORMS COMPARED
TABLE 15 KEY PERFORMANCE METRICS FOR SEQUENCING TECHNOLOGIES
TABLE 16 COST AND PERFORMANCE COMPARISON OF SELECTED NEXT- AND THIRD-GENERATION DNA SEQUENCING PLATFORMS
SEQUENCING PRODUCT LIFE CYCLE
TABLE 17 LIFE CYCLE OF DNA SEQUENCING TECHNOLOGIES
SEQUENCING INSTRUMENT CUMULATIVE INSTALLED BASE
FIGURE 18 GLOBAL CUMULATIVE INSTALLED BASE OF DNA SEQUENCERS, THROUGH APRIL 2010 (%)
SEQUENCE READ LENGTH
TABLE 18 READ LENGTHS FOR SELECTED SEQUENCING PLATFORMS
SEQUENCER PERFORMANCE SPACE
FIGURE 19 SEQUENCING COMPETITIVE MARKET SPACE
END-USER SWITCHING
PAIRED-END READS
TABLE 19 STRENGTHS AND LIMITATIONS OF PAIRED-END READS
BARCODING
DNA POLYMERASES
SEQUENCING BIOINFORMATICS
TABLE 20 INFORMATICS WORKFLOW FOR NEXT-GENERATION SEQUENCING
TECHNOLOGY CHALLENGES FOR NEXT-GENERATION PLATFORMS
TABLE 21 TECHNOLOGY CHALLENGES FOR NEXT-GENERATION SEQUENCING
CHAPTER FIVE: DNA SEQUENCING APPLICATIONS
INTRODUCTION
FIGURE 20 WHOLE GENOME SEQUENCING PROJECTS FOR PROKARYOTES AND EUKARYOTES, AS OF APRIL 2010 (NUMBER OF GENOMES SEQUENCED)
FIGURE 21 WHOLE GENOME SEQUENCING EUKARYOTIC PROJECTS, BY TYPE, AS OF APRIL 2010
RESEARCH AND DRUG DISCOVERY APPLICATIONS
INTRODUCTION
TABLE 22 GENETIC ANALYSIS FORMATS COMPARISON
TABLE 23 SEQUENCING APPLICATIONS
TABLE 24 DE NOVO VERSUS RESEQUENCING REQUIREMENTS
DE NOVO SEQUENCING
De Novo Human Sequencing
De Novo Microbial Sequencing
TABLE 25 CASE STUDY 1: NEANDERTHAL DNA SEQUENCING
RESEQUENCING
Whole Genome Resequencing (Genome-wide Association Studies or Loci Discovery)
FIGURE 22 RELATIVE NUMBER OF DISEASE-CAUSING ALLELES AT MAF5 AND MAF1
FIGURE 23 SINGLE SEQUENCER, WHOLE GENOME THROUGHPUT TRENDS 1975-2015
Targeted Resequencing
SEQ-BASED METHODS
TABLE 26 GENETIC ANALYSIS APPLICATIONS WHERE SEQUENCING COMPETES WITH MICROARRAYS
Chromatin Immunoprecipitation Applications
TABLE 27 COMPARISON OF SEQUENCING WITH MICROARRAYS FOR CHIP APPLICATIONS
DNase-seq
Gene Expression Analysis
TABLE 28 COMPARISON OF SEQUENCING AND MICROARRAYS FOR GENE EXPRESSION ANALYSIS
MethylSeq
DNA Mutation Studies
Complementary Sequencing and Microarray Platforms Drive Market Growth
DIAGNOSTICS AND DRUG DISCOVERY
FIGURE 24 APPLICATIONS SPACE WITH INTENSE TECHNOLOGY COMPETITION
FIGURE 25 APPLICATIONS SPACE WITH INTENSE TECHNOLOGY COMPETITION
PERSONAL GENOMICS
FIGURE 26 GENETIC ANALYSIS COST/INFORMATION CONTENT TRENDS
CHAPTER SIX: DNA SEQUENCING INITIATIVES
INTRODUCTION
FIGURE 27 NIH FUNDING AWARDS, BY INSTITUTE, FOR DNA SEQUENCING - RELATED PROJECTS, 2009-2010 (%)
NHGRI $1,000 GENOME PROJECT FUNDING
TABLE 29 NHGRI GRANTS UNDER $1,000 GENOME PROGRAM, FY2009 ($)
FIGURE 28 NHGRI $1,000 GENOME PROJECT AWARDS VALUE, FY2007- FY2009 ($ MILLIONS)
FIGURE 29 $1,000 GENOME PROJECT AWARDS, BY TECHNOLOGY, 2007-2009 (%)
SEQUENCING-RELATED GENOMICS PROJECTS OVERVIEW AND STATUS
TABLE 30 IMPORTANT SEQUENCING RESEARCH INITIATIVES
GENOME SEQUENCING PROJECTS
Functional Genomics in Norway (FUGE) II
Personal Genome Project
Archon X Prize in Genomics
Genomes 10K Project
1,000 Plant and Animal Reference Project
MEDICAL SEQUENCING PROJECTS
Mapped Autosomal Mendelian Disorders
Allelic Spectrum in Common Disease Program
Clinseq Project
CANCER SEQUENCING PROJECTS
Cancer Genome Project
Tumor Sequencing Project (TSP)
The Cancer Genome Atlas
MICROBIAL SEQUENCING PROJECTS
Human Microbiome Project
Microbial Genome Sequencing Project
Marine Microbial Genome Sequencing Project
Fungal Genome Initiative
Pathogen Sequencing Program
Genomic Encyclopedia of Bacteria and Archaea (GEBA)
Metagenomics of the Human Intestinal Tract (MetaHIT)
Gut Microbiome Initiative
10,000 Microbial Genomes Project
GENOME VARIATION PROJECTS
Encyclopedia of DNA Elements (ENCODE)
1,000 Genomes Project
1,000 Plant Genomes Project
Resequencing Technology Program
Human Genome Structural Variation Project
Yanhuang Project
AGRICULTURAL GENOMICS
National Plant Genome Initiative
EPIGENOMICS SEQUENCING PROJECTS
TABLE 31 EPIGENOMICS INITIATIVES
EUROPE
UNITED STATES
ASIA
IMPACT OF SEQUENCING PROJECTS
FIGURE 30 GROWTH IN BASE PAIRS DEPOSITED IN GENBANK, 1988-2008 (BILLIONS)
CHAPTER SEVEN: DNA SEQUENCING INDUSTRY STRUCTURE
INDUSTRY STRUCTURE ANALYSIS
FIGURE 31 DNA SEQUENCING INDUSTRY STRUCTURE, 1995-2005
FIGURE 32 DNA SEQUENCING INDUSTRY STRUCTURE: POST 2005
TABLE 32 DNA SEQUENCING INDUSTRY TRANSITION
THE ROLE OF EARLY ADAPTORS
SEQUENCING INSTRUMENT COMPETITOR POSITIONING
FIGURE 33 SEQUENCER PLATFORM POSITIONING BY READS AND READ LENGTH
TABLE 33 SEQUENCING INSTRUMENT COMPETITORS, BY TECHNOLOGY
SEQUENCING SAMPLE PREPARATION INDUSTRY
TABLE 34 POSITIONING OF SEQUENCE ENRICHMENT FORMATS
TABLE 35 SEQUENCING SAMPLE PREPARATION COMPANY POSITIONING
SEQUENCING BIOINFORMATICS INDUSTRY
TABLE 36 DNA SEQUENCING BIOINFORMATICS COMPANY POSITIONING
SEQUENCING SERVICES INDUSTRY
TABLE 37 DNA SEQUENCING SERVICES COMPANY POSITIONING, BY MARKET FOCUS
SEQUENCING INSTRUMENTS COMPETITOR MARKET SHARES
FIGURE 34 ESTIMATED COMPETITOR MARKET SHARE: SEQUENCING INSTRUMENTS AND REAGENTS, 2009 (%)
FIGURE 35 ESTIMATED COMPETITOR MARKET SHARE: SANGER SEQUENCING INSTRUMENTS AND REAGENTS, 2009 (TOTAL MARKET $466.2 MILLION) (%)
FIGURE 36 ESTIMATED COMPETITOR MARKET SHARE: NEXTGENERATION SEQUENCING INSTRUMENTS AND REAGENTS, 2009 (TOTAL MARKET $607.4 MILLION) (%)
INDUSTRY ACQUISITIONS AND STRATEGIC ALLIANCES
TABLE 38 SEQUENCING INDUSTRY ACQUISITIONS, 2007-2010
TABLE 39 SEQUENCING INDUSTRY STRATEGIC ALLIANCES, 2007-2010
SEQUENCING REAGENTS SUPPLY ALLIANCES
PERSONAL GENOMICS INDUSTRY DYNAMICS
TABLE 40 MEDIUM TO HIGH CONTENT DTC GENETIC TESTING KEY COMPETITORS
FIGURE 37 PERSONAL GENOMICS COMPETITIVE SPACE, BY TEST COST AND SCOPE
TABLE 41 PERSONAL GENOMICS COMPETITOR STRATEGIES
DNA SEQUENCING END USERS
TABLE 42 DNA SEQUENCING END-USER MARKET SEGMENTS
Major Sequencing Centers
TABLE 43 NEXT-GENERATION SEQUENCING INSTRUMENT INSTALLATIONS, BY MAJOR SEQUENCING CENTER, 2010
FIGURE 38 MAJOR SEQUENCING CENTER’S SHARE OF THE GENOME SEQUENCING PROJECTS MARKET BY NUMBER OF SEQUENCING PROJECTS, APRIL 2010 (%)
FIGURE 39 BEIJING GENOMICS INSTITUTE ADOPTION OF NEXTGENERATION SEQUENCERS, 2008 AND 2010 (NUMBER OF SEQUENCERS)
Large Core Sequencing Centers
TABLE 44 EXAMPLES OF LARGE CORE SEQUENCING CENTERS
Small to Mid-size Laboratories
Sequencing Service Laboratories
CHAPTER EIGHT: DNA SEQUENCING MARKETS
GROWTH DRIVING FORCES
TABLE 45 DNA SEQUENCING KEY GROWTH DRIVING FORCES
FIGURE 40 EUKARYOTIC SEQUENCING PARADIGM
GENETIC ANALYSIS MARKETS
TABLE 46 GLOBAL VALUE OF GENETIC ANALYSIS MARKET, BY ANALYSIS TYPE, THROUGH 2015 ($ MILLIONS)
FIGURE 41 SNP GENOTYPING MARKET
DNA SEQUENCING PRODUCTS MARKETS
DNA SEQUENCING MARKETS BY PRODUCT TYPE
TABLE 47 GLOBAL VALUE OF DNA SEQUENCING WORKFLOW PRODUCTS, BY TYPE, THROUGH 2015 ($ MILLIONS)
TABLE 48 GLOBAL VALUE OF DNA SEQUENCING INSTRUMENT AND CONSUMABLES MARKET, BY PRODUCT TYPE, THROUGH 2015 ($ MILLIONS)
DNA SEQUENCING MARKETS BY SANGER AND NEXTGENERATION FORMATS
FIGURE 42 GLOBAL VALUE OF SEQUENCING INSTRUMENTS AND CONSUMABLES, BY TECHNOLOGY PLATFORM, 2010 AND 2015 (DOLLARS)
TABLE 49 GLOBAL VALUE OF DNA SEQUENCING INSTRUMENTS, BY PLATFORM, THROUGH 2015 ($ MILLIONS)
TABLE 50 GLOBAL VALUE OF DNA SEQUENCING CONSUMABLES MARKET, BY PLATFORM, THROUGH 2015 ($ MILLIONS)
DNA SEQUENCING MARKETS BY END USER
TABLE 51 GLOBAL VALUE OF DNA SEQUENCING INSTRUMENTS AND CONSUMABLES, BY CUSTOMER TYPE, THROUGH 2015 ($ MILLIONS)
TABLE 52 GLOBAL VALUE OF SANGER SEQUENCING INSTRUMENTS AND CONSUMABLES, BY CUSTOMER, THROUGH 2015 ($ MILLIONS)
TABLE 53 GLOBAL VALUE OF NEXT-GENERATION SEQUENCING INSTRUMENTS AND CONSUMABLES, BY CUSTOMER, THROUGH 2015 ($ MILLIONS)
DNA SEQUENCING MARKETS BY TECHNOLOGY
TABLE 54 GLOBAL VALUE OF DNA SEQUENCING INSTRUMENTS AND CONSUMABLES MARKET, BY TECHNOLOGY, THROUGH 2015 ($ MILLIONS)
DNA SEQUENCING MARKETS BY END-USER APPLICATION
TABLE 55 GLOBAL VALUE OF DNA SEQUENCING, BY END-USE APPLICATION, THROUGH 2015 ($ MILLIONS)
Research and Drug Discovery and Development
Forensic and Human ID
Bacterial Genomics
Agricultural Genomics
Clinical Diagnostics
TABLE 56 LABORATORIES DEVELOPING NEXT-GENERATION SEQUENCING DX TESTS
Personal Genomics
Other Applications
TABLE 57 GLOBAL VALUE OF NEXT-GENERATION SEQUENCING INSTRUMENTS AND CONSUMABLES, BY END-USE APPLICATION, THROUGH 2015 ($ MILLIONS)
TABLE 58 GLOBAL VALUE OF SANGER SEQUENCING INSTRUMENTS AND CONSUMABLES, BY END-USE APPLICATION, THROUGH 2015 ($ MILLIONS)
DNA SEQUENCING MARKETS BY GENOME TYPE
TABLE 59 GLOBAL VALUE OF SEQUENCING, BY GENOME TYPE, THROUGH 2015 ($ MILLIONS)
DNA SEQUENCING MARKETS BY ANALYSIS TYPE
TABLE 60 GLOBAL VALUE OF DNA SEQUENCING, BY ANALYSIS TYPE, THROUGH 2015 ($ MILLIONS)
TABLE 61 GLOBAL VALUE OF NEXT-GENERATION SEQUENCING, BY ANALYSIS TYPE, THROUGH 2015 ($ MILLIONS)
TABLE 62 GLOBAL VALUE OF SANGER SEQUENCING, BY ANALYSIS TYPE, THROUGH 2015 ($ MILLIONS)
DNA SEQUENCING MARKETS BY GEOGRAPHY
TABLE 63 GLOBAL VALUE OF DNA SEQUENCING PRODUCTS, BY GEOGRAPHICAL MARKET, THROUGH 2015 ($ MILLIONS)
TABLE 64 GLOBAL VALUE OF SANGER SEQUENCING PRODUCTS, BY GEOGRAPHICAL MARKET, THROUGH 2015 ($ MILLIONS)
TABLE 65 GLOBAL VALUE OF NEXT-GENERATION SEQUENCING PRODUCTS, BY GEOGRAPHICAL MARKET, THROUGH 2015 ($ MILLIONS)
CHAPTER NINE: DNA SEQUENCING PATENT STATUS
RECENT PATENT ACTIVITY IN NEXT-GENERATION DNA SEQUENCING
TABLE 66 NEXT-GENERATION SEQUENCING PATENT RECENT ACTIVITY
Sequencing by Synthesis
Single-molecule Sequencing
Nanopore Sequencing
Polony Sequencing
Nucleotide Modifications and Analogs
DNA Polymerases
Paired-end Inventions
Other Methods
PATENT POSITION OF SEQUENCING COMPETITORS
FIGURE 43 SEQUENCING-RELATED PATENTS, BY COMPANY (NUMBER OF PATENTS)
TECHNOLOGY DISTRIBUTION OF NEXT-GENERATION SEQUENCING PATENTS
FIGURE 44 GLOBAL NEXT-GENERATION SEQUENCING PATENTS, BY TECHNOLOGY, 2001-2009
GEOGRAPHICAL DISTRIBUTION OF NEXT-GENERATION SEQUENCING PATENTS
FIGURE 45 GLOBAL NEXT-GENERATION SEQUENCING-RELATED PATENTS, BY GEOGRAPHY, 2000-2009 (NUMBER OF PATENTS)
SEQUENCING LITIGATION STATUS
TABLE 67 SEQUENCING IP LITIGATION STATUS
INTELLECTUAL PROPERTY POSITION OF SELECTED SEQUENCING COMPANIES
LIFE TECHNOLOGIES
LI-COR BIOSCIENCES
HELICOS BIOSCIENCES
ILLUMINA
INTELLIGENT BIO-SYSTEMS
PACIFIC BIOSCIENCES
CHAPTER TEN: COMPANY PROFILES
23ANDME
AFFOMIX CORPORATION
AFFYMETRIX, INC.
AGILENT TECHNOLOGIES, INC.
ARTEMIS HEALTH, INC.
BASE4INNOVATION, LTD.
BECKMAN COULTER
BIO.LOGIS CENTER FOR HUMAN GENETICS
BIONANOMATRIX, INC.
BIOTIQUE SYSTEMS INC.
CALIPER LIFE SCIENCES
COLLABRX, INC.
COMPLETE GENOMICS, INC.
CONEXIO GENOMICS
CORRELAGEN DIAGNOSTICS, INC.
DANAHER MOTION
DECODEME
DELTADOT, LTD.
DNANEXUS, INC.
DNA STAR, INC.
ELECTRONIC BIOSCIENCES
EUROFINS MEDIGENOMIX GMBH
EXPRESSION ANALYSIS, INC.
FASTERIS SA
FEBIT BIOTECH GMBH
FIREBIRD BIOMOLECULAR SCIENCES, LLC
FLUIDIGM CORPORATION
FOUNDATION FOR APPLIED MOLECULAR EVOLUTION
GATC BIOTECH AG
GE HEALTHCARE
GENEDATA AG
GENOME DIAGNOSTICS B.V
GENOMEQUEST, INC.
GENOMATIX SOFTWARE, INC.
GENOVOXX GMBH
GEOSPIZA, INC.
HALCYON MOLECULAR
HELICOS BIOSCIENCES CORPORATION
INTERNATIONAL BUSINESS MACHINES CORP.
ILLUMINA, INC.
TABLE 68 ILLUMINA SEQUENCING TECHNOLOGY SPACE
INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
INTELLIGENT BIO-SYSTEMS
INTERNA GENOMICS BV
ION TORRENT SYSTEMS
IP GENESIS INC.
ISENTIO AS
KNOME, INC.
LASERGEN, INC.
LI-COR BIOSCIENCES
LIFE TECHNOLOGIES, INC.
LIFECODEXX
LIGHTSPEED GENOMICS
LINGVITAE AS
MICROCHIP BIOTECHNOLOGIES, INC.
MWG BIOTECH AG
MYCROARRAY.COM
NABSYS, INC.
NAVIGENICS
NETWORK BIOSYSTEMS
NEWGENE, LTD.
NUGEN TECHNOLOGIES, INC.
OLINK GENOMICS AB
OPGEN, INC.
OXFORD NANOPORE TECHNOLOGIES
PACIFIC BIOSCIENCES
POPULATION GENETICS TECHNOLOGIES, LTD.
QUANTALIFE, INC.
RAINDANCE TECHNOLOGIES, INC.
REAL TIME GENOMICS
REVEO INC.
ROCHE LIFE SCIENCES
SEIRAD, INC.
SEQUENOM, INC.
SEQWRIGHT
SHIMADZU SCIENTIFIC INSTRUMENTS
SMARTGENE
SOURCE BIOSCIENCES, PLC.
SORENSON GENOMICS
U.S. GENOMICS
VISIGEN BIOTECHNOLOGIES, INC.
X-PRIZE FOUNDATION
ZS GENETICS
LIST OF TABLES
SUMMARY TABLE GLOBAL VALUE OF DNA SEQUENCING
PRODUCTS, BY END-USE APPLICATION, THROUGH 2015 ($
MILLIONS)
TABLE 1 SCOPE OF THIS REPORT
TABLE 2 GLOBAL VALUE OF DNA SEQUENCING WORKFLOW
PRODUCTS, BY TYPE, THROUGH 2015 ($ MILLIONS)
TABLE 3 DNA SEQUENCING KEY GROWTH DRIVING FORCES
TABLE 4 PRODUCT LIFE CYCLE STATUS OF SEQUENCING
PLATFORMS
TABLE 5 SEQUENCING INSTRUMENT COMPETITORS, BY
TECHNOLOGY
TABLE 6 SCOPE OF KEY GENETIC ANALYSIS TECHNOLOGIES
TABLE 7 DNA SEQUENCING HISTORICAL TIMELINE
TABLE 8 DNA SEQUENCING TECHNOLOGY PLATFORM
COMPARISON
TABLE 9 LIMITATIONS OF SANGER SEQUENCING TECHNOLOGY
TABLE 10 IMPROVEMENTS IN SANGER SEQUENCING TECHNOLOGY
TABLE 11 NEXT-GENERATION SEQUENCING WORKFLOW STEPS
TABLE 12 WORKFLOW COMPARISON OF SELECTED NEXTGENERATION
DNA SEQUENCING PLATFORMS
TABLE 13 NEXT-GENERATION SEQUENCE PLATFORMS
TABLE 14 NEXT-GENERATION SEQUENCING PLATFORM
ADVANTAGES AND LIMITATIONS
TABLE 15 KEY PERFORMANCE METRICS FOR SEQUENCING
TECHNOLOGIES
TABLE 16 COST AND PERFORMANCE COMPARISON OF SELECTED
NEXT- AND THIRD-GENERATION DNA SEQUENCING PLATFORMS
TABLE 17 LIFE CYCLE OF DNA SEQUENCING TECHNOLOGIES
TABLE 18 READ LENGTHS FOR SELECTED SEQUENCING
PLATFORMS
TABLE 19 STRENGTHS AND LIMITATIONS OF PAIRED-END READS
TABLE 20 INFORMATICS WORKFLOW FOR NEXT-GENERATION
SEQUENCING
TABLE 21 TECHNOLOGY CHALLENGES FOR NEXT-GENERATION
SEQUENCING
TABLE 22 GENETIC ANALYSIS FORMATS COMPARISON
TABLE 23 SEQUENCING APPLICATIONS
TABLE 24 DE NOVO VERSUS RESEQUENCING REQUIREMENTS
TABLE 25 CASE STUDY 1: NEANDERTHAL DNA SEQUENCING
TABLE 26 GENETIC ANALYSIS APPLICATIONS WHERE SEQUENCING
COMPETES WITH MICROARRAYS
TABLE 27 COMPARISON OF SEQUENCING WITH MICROARRAYS FOR
CHIP APPLICATIONS
TABLE 28 COMPARISON OF SEQUENCING AND MICROARRAYS FOR
GENE EXPRESSION ANALYSIS
TABLE 29 NHGRI GRANTS UNDER $1,000 GENOME PROGRAM, FY2009
($)
TABLE 30 IMPORTANT SEQUENCING RESEARCH INITIATIVES
TABLE 31 EPIGENOMICS INITIATIVES
TABLE 32 DNA SEQUENCING INDUSTRY TRANSITION
TABLE 33 SEQUENCING INSTRUMENT COMPETITORS, BY
TECHNOLOGY
TABLE 34 POSITIONING OF SEQUENCE ENRICHMENT FORMATS
TABLE 35 SEQUENCING SAMPLE PREPARATION COMPANY
POSITIONING
TABLE 36 DNA SEQUENCING BIOINFORMATICS COMPANY
POSITIONING
TABLE 37 DNA SEQUENCING SERVICES COMPANY POSITIONING,
BY MARKET FOCUS
TABLE 38 SEQUENCING INDUSTRY ACQUISITIONS, 2007-2010
TABLE 39 SEQUENCING INDUSTRY STRATEGIC ALLIANCES, 2007-
2010
TABLE 40 MEDIUM TO HIGH CONTENT DTC GENETIC TESTING KEY
COMPETITORS
TABLE 41 PERSONAL GENOMICS COMPETITOR STRATEGIES
TABLE 42 DNA SEQUENCING END-USER MARKET SEGMENTS
TABLE 43 NEXT-GENERATION SEQUENCING INSTRUMENT
INSTALLATIONS, BY MAJOR SEQUENCING CENTER, 2010
TABLE 44 EXAMPLES OF LARGE CORE SEQUENCING CENTERS
TABLE 45 DNA SEQUENCING KEY GROWTH DRIVING FORCES
TABLE 46 GLOBAL VALUE OF GENETIC ANALYSIS MARKET, BY
ANALYSIS TYPE, THROUGH 2015 ($ MILLIONS)
TABLE 47 GLOBAL VALUE OF DNA SEQUENCING WORKFLOW
PRODUCTS, BY TYPE, THROUGH 2015 ($ MILLIONS)
TABLE 48 GLOBAL VALUE OF DNA SEQUENCING INSTRUMENT AND
CONSUMABLES MARKET, BY PRODUCT TYPE, THROUGH 2015 ($
MILLIONS)
TABLE 49 GLOBAL VALUE OF DNA SEQUENCING INSTRUMENTS, BY
PLATFORM, THROUGH 2015 ($ MILLIONS)
TABLE 50 GLOBAL VALUE OF DNA SEQUENCING CONSUMABLES
MARKET, BY PLATFORM, THROUGH 2015 ($ MILLIONS)
TABLE 51 GLOBAL VALUE OF DNA SEQUENCING INSTRUMENTS
AND CONSUMABLES, BY CUSTOMER TYPE, THROUGH 2015 ($
MILLIONS)
TABLE 52 GLOBAL VALUE OF SANGER SEQUENCING INSTRUMENTS
AND CONSUMABLES, BY CUSTOMER, THROUGH 2015 ($
MILLIONS)
TABLE 53 GLOBAL VALUE OF NEXT-GENERATION SEQUENCING
INSTRUMENTS AND CONSUMABLES, BY CUSTOMER, THROUGH
2015 ($ MILLIONS)
TABLE 54 GLOBAL VALUE OF DNA SEQUENCING INSTRUMENTS
AND CONSUMABLES MARKET, BY TECHNOLOGY, THROUGH 2015
($ MILLIONS)
TABLE 55 GLOBAL VALUE OF DNA SEQUENCING, BY END-USE
APPLICATION, THROUGH 2015 ($ MILLIONS)
TABLE 56 LABORATORIES DEVELOPING NEXT-GENERATION
SEQUENCING DX TESTS
TABLE 57 GLOBAL VALUE OF NEXT-GENERATION SEQUENCING
INSTRUMENTS AND CONSUMABLES, BY END-USE APPLICATION,
THROUGH 2015 ($ MILLIONS)
TABLE 58 GLOBAL VALUE OF SANGER SEQUENCING INSTRUMENTS
AND CONSUMABLES, BY END-USE APPLICATION, THROUGH 2015
($ MILLIONS)
TABLE 59 GLOBAL VALUE OF SEQUENCING, BY GENOME TYPE,
THROUGH 2015 ($ MILLIONS)
TABLE 60 GLOBAL VALUE OF DNA SEQUENCING, BY ANALYSIS
TYPE, THROUGH 2015 ($ MILLIONS)
TABLE 61 GLOBAL VALUE OF NEXT-GENERATION SEQUENCING, BY
ANALYSIS TYPE, THROUGH 2015 ($ MILLIONS)
TABLE 62 GLOBAL VALUE OF SANGER SEQUENCING, BY ANALYSIS
TYPE, THROUGH 2015 ($ MILLIONS)
TABLE 63 GLOBAL VALUE OF DNA SEQUENCING PRODUCTS, BY
GEOGRAPHICAL MARKET, THROUGH 2015 ($ MILLIONS)
TABLE 64 GLOBAL VALUE OF SANGER SEQUENCING PRODUCTS, BY
GEOGRAPHICAL MARKET, THROUGH 2015 ($ MILLIONS)
TABLE 65 GLOBAL VALUE OF NEXT-GENERATION SEQUENCING
PRODUCTS, BY GEOGRAPHICAL MARKET, THROUGH 2015 ($
MILLIONS)
TABLE 66 NEXT-GENERATION SEQUENCING PATENT RECENT
ACTIVITY
TABLE 67 SEQUENCING IP LITIGATION STATUS
TABLE 68 ILLUMINA SEQUENCING TECHNOLOGY SPACE
LIST OF FIGURES
SUMMARY FIGURE GLOBAL VALUE OF DNA SEQUENCING
PRODUCTS, BY END-USE APPLICATION, 2009-2015 ($ MILLIONS)
FIGURE 1 CENTRAL MOLECULAR BIOLOGY DOGMA
FIGURE 2 DNA, MRNA, AND GENETIC VARIATION
FIGURE 3 SEQUENCING COST TREND, BASE PAIRS SEQUENCED PER
DOLLAR
FIGURE 4 SEQUENCING THROUGHPUT TREND
FIGURE 5 HUMAN GENOME SEQUENCING COST TREND (DOLLARS)
FIGURE 6 $1,000 GENOME PRODUCT SPACE
FIGURE 7 DDNTP CHEMICAL STRUCTURE
FIGURE 8 SANGER SEQUENCING WORKFLOW
FIGURE 9 COST BREAKDOWN FOR SEQUENCING A SINGLE HUMAN
GENOME, USING 2005 SANGER SEQUENCER TECHNOLOGY (%)
FIGURE 10 NEXT-GENERATION SEQUENCING TECHNOLOGIES
FIGURE 11 SCHEMATIC COMPARISON OF ROCHE/454, LIFE
TECHNOLOGIES, AND ILLUMINA SEQUENCING PLATFORMS
FIGURE 12 SEQUENCING BY SYNTHESIS: REVERSIBLE
TERMINATOR REACTION
FIGURE 13 SEQUENCING BY SYNTHESIS: PYROSEQUENCING
REACTION
FIGURE 14 SCHEMATIC OF SOLID SEQUENCING BY LIGATION
FIGURE 15 DECODING SOLID COLOR DATA
FIGURE 16 SINGLE-MOLECULE SEQUENCING BY SYNTHESIS
FIGURE 17 NANOPORE SEQUENCING WORKFLOW AND
TECHNOLOGY APPROACHES
FIGURE 18 GLOBAL CUMULATIVE INSTALLED BASE OF DNA
SEQUENCERS, THROUGH APRIL 2010 (%)
FIGURE 19 SEQUENCING COMPETITIVE MARKET SPACE
FIGURE 20 WHOLE GENOME SEQUENCING PROJECTS FOR
PROKARYOTES AND EUKARYOTES, AS OF APRIL 2010 (NUMBER
OF GENOMES SEQUENCED)
FIGURE 21 WHOLE GENOME SEQUENCING EUKARYOTIC PROJECTS,
BY TYPE, AS OF APRIL 2010
FIGURE 22 RELATIVE NUMBER OF DISEASE-CAUSING ALLELES AT
MAF5 AND MAF1
FIGURE 23 SINGLE SEQUENCER, WHOLE GENOME THROUGHPUT
TRENDS 1975-2015
FIGURE 24 APPLICATIONS SPACE WITH INTENSE TECHNOLOGY
COMPETITION
FIGURE 25 APPLICATIONS SPACE WITH INTENSE TECHNOLOGY
COMPETITION
FIGURE 26 GENETIC ANALYSIS COST/INFORMATION CONTENT
TRENDS
FIGURE 27 NIH FUNDING AWARDS, BY INSTITUTE, FOR DNA
SEQUENCING - RELATED PROJECTS, 2009-2010 (%)
FIGURE 28 NHGRI $1,000 GENOME PROJECT AWARDS VALUE,
FY2007- FY2009 ($ MILLIONS)
FIGURE 29 $1,000 GENOME PROJECT AWARDS, BY TECHNOLOGY,
2007 THROUGH 2009 (%)
FIGURE 30 GROWTH IN BASE PAIRS DEPOSITED IN GENBANK, 1988-
2008 (BILLIONS)
FIGURE 31 DNA SEQUENCING INDUSTRY STRUCTURE, 1995-2005
FIGURE 32 DNA SEQUENCING INDUSTRY STRUCTURE: POST 2005
FIGURE 33 SEQUENCER PLATFORM POSITIONING BY READS AND
READ LENGTH
FIGURE 34 ESTIMATED COMPETITOR MARKET SHARE:
SEQUENCING INSTRUMENTS AND REAGENTS, 2009 (%)
FIGURE 35 ESTIMATED COMPETITOR MARKET SHARE: SANGER
SEQUENCING INSTRUMENTS AND REAGENTS, 2009 (TOTAL
MARKET $466.2 MILLION) (%)
FIGURE 36 ESTIMATED COMPETITOR MARKET SHARE: NEXTGENERATION
SEQUENCING INSTRUMENTS AND REAGENTS, 2009
(TOTAL MARKET $607.4 MILLION) (%)
FIGURE 37 PERSONAL GENOMICS COMPETITIVE SPACE, BY TEST
COST AND SCOPE
FIGURE 38 MAJOR SEQUENCING CENTER’S SHARE OF THE GENOME
SEQUENCING PROJECTS MARKET BY NUMBER OF SEQUENCING
PROJECTS, APRIL 2010 (%)
FIGURE 39 BEIJING GENOMICS INSTITUTE ADOPTION OF NEXTGENERATION
SEQUENCERS, 2008 AND 2010 (NUMBER OF
SEQUENCERS)
FIGURE 40 EUKARYOTIC SEQUENCING PARADIGM
FIGURE 41 SNP GENOTYPING MARKET
FIGURE 42 GLOBAL VALUE OF SEQUENCING INSTRUMENTS AND
CONSUMABLES, BY TECHNOLOGY PLATFORM, 2010 AND 2015
(DOLLARS)
FIGURE 43 SEQUENCING-RELATED PATENTS, BY COMPANY
(NUMBER OF PATENTS)
FIGURE 44 GLOBAL NEXT-GENERATION SEQUENCING PATENTS, BY
TECHNOLOGY, 2001-2009
FIGURE 45 GLOBAL NEXT-GENERATION SEQUENCING-RELATED
PATENTS, BY GEOGRAPHY, 2000-2009 (NUMBER OF PATENTS)

For full details, please email keithw@cmsinfo.com

Top of Page

Buy now!

Paper
 GBP 3372.00   

PDF Single User License
 GBP 3344.00   

PDF Single Site License
 GBP 4103.00   

PDF Global Site License
 GBP 5862.00   

Your personal guarantee

Top of Page

Home | About | Market Research by Sector |
Pharmaceutical Research Firms | faq | Privacy | Terms
Site Contents

Office Address: Chiltern Magazine Services Ltd., P&A House, Alma Road, Chesham, Bucks. HP5 3HB, UK.

Telephone: UK +44 (0) 1494 771734 Fax: +44 (0) 01494 778994 e-mail: keithw@cmsinfo.com
Telephone: USA +(1) 508 861 0401 Fax: +(1) 508 861 0401

Registered Office: 2a Altons House Office Park, Gatehouse Way, Aylesbury, HP19 3XU, UK
Registered in England and Wales No. 3240740 VAT No. GB 685 4343 10

CMSInfo (Chiltern Magazine Services Ltd.) is a company registered at Companies House in England and Wales (Company No. 3240740).
CMSInfo is also registered in accordance with the Data Protection Act 1998 (registration number R0094104).

Terms and Conditions


Site maintenance by R V Williams